Exact Sciences Cor (EXAS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -164,272 | -126,036 | -110,228 | -204,149 | -154,383 |
| Depreciation Amortization | 193,008 | 119,539 | 58,389 | 207,229 | 153,057 |
| Income taxes - deferred | 1,827 | 2,225 | 1,797 | -955 | -279 |
| Accounts receivable | -61,410 | -60,901 | -37,536 | -43,416 | -40,306 |
| Accounts payable and accrued liabilities | 38,258 | -17,865 | -53,515 | 82,750 | 51,084 |
| Other Working Capital | -34,540 | -78,967 | -108,209 | -342 | -26,997 |
| Other Operating Activity | 190,602 | 186,759 | 166,991 | 115,002 | 104,394 |
| Operating Cash Flow | $163,473 | $24,754 | $-82,311 | $156,119 | $86,570 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -254,469 | -244,037 | -133,347 | 223,302 | 252,958 |
| PPE Investments | -144,673 | -73,515 | -37,649 | -124,690 | -89,268 |
| Net Acquisitions | N/A | N/A | N/A | -52,413 | -50,000 |
| Purchase Of Investment | -916 | -810 | N/A | -16,564 | -6,290 |
| Sale Of Investment | N/A | N/A | N/A | 19,794 | 9,296 |
| Other Investing Activity | -225 | -205 | -442 | 250 | -250 |
| Investing Cash Flow | $-400,283 | $-318,567 | $-171,438 | $49,679 | $116,446 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 266,750 | 266,750 | N/A | 137,976 | 137,976 |
| Common Stock Issued | 20,169 | 18,037 | -1,408 | 31,541 | 19,237 |
| Other Financing Activity | -65,544 | -63,186 | -1,594 | -9,751 | -7,484 |
| Financing Cash Flow | $221,375 | $221,601 | $-3,002 | $159,766 | $149,729 |
| Exchange Rate Effect | 427 | -1,446 | -1,140 | 1,321 | -626 |
| Beginning Cash Position | 609,675 | 609,675 | 609,675 | 242,790 | 242,790 |
| End Cash Position | 594,667 | 536,017 | 351,784 | 609,675 | 594,909 |
| Net Cash Flow | $-15,008 | $-73,658 | $-257,891 | $366,885 | $352,119 |
| Free Cash Flow | |||||
| Operating Cash Flow | 163,473 | 24,754 | -82,311 | 156,119 | 86,570 |
| Capital Expenditure | -144,673 | -73,515 | -37,649 | -124,690 | -89,268 |
| Free Cash Flow | 18,800 | -48,761 | -119,960 | 31,429 | -2,698 |